TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ALKS

Alkermes Plc

Healthcare · Drug Manufacturers - Specialty & Generic

43.40$ -7.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ALKS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1.8% -6.4% -8.6% 2.1% 9.1% 6.2% 8.0% 8.7% 1.9% 24.1% 28.2% 35.3%
15.9% 13.6% 12.6% 10.9% 9.5% 6.9% 7.9% 6.7% 7.0% 4.5% 1.8% 1.8%
9.6% 15.5% 12.7% 9.3% 9.6% 8.6% 8.7% 7.5% 8.5% 6.1% 6.2% 6.7%
-6.2% 3.1% 10.4% 9.2% 13.2% 10.5% 9.5% 8.2% 8.0%
1.8% 13.0% -3.6% -0.5% -0.7% 5.6% 1.3% -2.2% 1.1% -2.2% -6.3% 8.1%
5.4% 8.4% 5.9% 5.7% 6.3% 7.8% 4.1% 2.5% 3.4% 2.9% 2.1% 2.7%
-42.6% -6.9% 17.1% -2.0% -2.0% -12.1% -1.1% -5.6% -5.8% 3.2% -7.1% 20.0%
0.0% 0.0% 0.0% 0.0% 0.8% 0.1% 0.7% 0.1%
-2.1% -4.1% -1.8% -1.8% -1.8% -0.8% -0.7% -1.4% -1.6% -1.7% -12.9% -2.1%
-1.1% -1.1% -9.3% -0.3% -0.3% -0.2% -0.3% 1.7% -0.3% -0.2% -18.7% 0.0%
49.9% 6.5% -7.8% 0.5% -0.1% 0.6% -0.2% 2.5% -0.1% -17.4% -31.7% 0.8%
9.1% -6.8% 0.7% 0.5% 6.9% -5.4% 6.7% 5.5% -4.1% 9.9% -10.7% 56.1%
-3.6% -14.8% -14.4% -3.6% 2.7% -1.6% 3.9% 6.2% -1.5% 21.2% 26.0% 32.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?